Skip to main content
SpringerLink
Log in

Psoriatic Arthritis

  • Chapter
Psoriasis and Psoriatic Arthritis

  • 1379 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Deandrade JR, Casagrande PA (1965) A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 19: 302–334

    Google Scholar 

  2. Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA (1992) Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 19: 1115–1119

    PubMed  CAS  Google Scholar 

  3. Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P, et al. (1990) Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 17: 62–64

    PubMed  CAS  Google Scholar 

  4. Kaltwasser J, Nash P, Gladman D, Rosen C, Behrens F, Mease P (2003) Leflunomide in the treatment of psoriatic arthritis and psoriasis: data from a doubleblind, randomized, placebo-controlled clinical trial. Ann Rheum Dis 62(Suppl 1): abstract #OP0081

    Google Scholar 

  5. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385–390

    Article  PubMed  CAS  Google Scholar 

  6. Mease P, Kivitz A, Burch F, Siegel E, Cohen S, Burge D (2001) Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract]. Arthritis Rheum 44(Suppl 9): S90

    Google Scholar 

  7. Antoni C, Kavanaugh A, Kirkham B, Burmester G, Weisman M, Keystone E, et al. (2002) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [abstract]. Arthritis Rheum 46(Suppl 9): S381

    Google Scholar 

  8. Gladman DD (1998) Psoriatic arthritis. Rheum Dis Clin North Am 24: 829–844

    Article  PubMed  CAS  Google Scholar 

  9. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393–406

    PubMed  CAS  Google Scholar 

  10. Thompson PW, Hart LE, Goldsmith CH, Spector TD, Bell MJ, Ramsden MF (1991) Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation. J Rheumatol 18: 661–665

    PubMed  CAS  Google Scholar 

  11. Ujfalussy I, Koo E (2003) Measurement of disease activity in psoriatic arthritis. Extended report. Z Rheumatol 62: 60–65

    Article  PubMed  CAS  Google Scholar 

  12. Macrae IF, Wright V (1969) Measurement of back movement. Ann Rheum Dis 28: 584–589

    Article  PubMed  CAS  Google Scholar 

  13. Portek I, Pearcy MJ, Reader GP, Mowat AG (1983) Correlation between radiographic and clinical measurement of lumbar spine movement. Br J Rheumatol 22: 197–205

    Article  PubMed  CAS  Google Scholar 

  14. Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al. (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48: 3230–3236

    Article  PubMed  CAS  Google Scholar 

  15. Pile KD, Laurent MR, Salmond CE, Best MJ, Pyle EA, Moloney RO (1991) Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. Br J Rheumatol 30: 29–34

    Article  PubMed  CAS  Google Scholar 

  16. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21: 1694–1698

    PubMed  CAS  Google Scholar 

  17. Gladman DD, Cook RJ, Schentag C, Feletar M, Inman R, Hitchon C, et al. (2003) The Clinical Assessment of Patients with Psoriatic Arthritis (PsA): Results of a Validation Study of the Spondyloarthritis Research Consortium of Canada. Arthritis Rheum 48(Suppl 9): S168

    Google Scholar 

  18. Frediani B, Falsetti P, Storri L, Allegri A, Bisogno S, Baldi F, et al. (2002) Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 21: 203–206

    Article  PubMed  Google Scholar 

  19. McGonagle D, Gibbon W, O’Connor P, Green M, Pease C, Emery P (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 41: 694–700

    Article  PubMed  CAS  Google Scholar 

  20. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD (2002) Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 61: 905–910

    Article  PubMed  CAS  Google Scholar 

  21. Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46: 197–202

    Article  PubMed  CAS  Google Scholar 

  22. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R, van der Tempel H, Mielants H, et al. (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62: 127–132

    Article  PubMed  CAS  Google Scholar 

  23. Antoni CE, Kavanaugh A, Kirkham B, Burmester G, Manger B, Tutuncu Z, et al. (2003) The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): Substantial Efficacy on Synovitis and Psoriatic Lesions With or Without DMARD Therapy. Ann Rheum Dis 62(Suppl 1): abstract #OP0082

    Google Scholar 

  24. Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O (1999) Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 26: 1746–1751

    PubMed  CAS  Google Scholar 

  25. Olivieri I, Barozzi L, Favaro L, Pierro A, de Matteis M, Borghi C, et al. (1996) Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 39: 1524–1528

    Article  PubMed  CAS  Google Scholar 

  26. Brockbank J, Stein M, Schentag CT, Gladman DD (2000) Characteristics of dactylitis in psoriatic arthritis (abst.). Arthritis Rheum 43(Suppl 9): S105

    Google Scholar 

  27. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26: 980–984

    PubMed  CAS  Google Scholar 

  28. Gladman DD, Rahman P (2001) Psoriatic arthritis, 6th edn, Chap 71. WB Saunders, Philadelphia

    Google Scholar 

  29. Helliwell PS, Marchesoni A, Peters M, Platt R, Wright V (1991) Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Ann Rheum Dis 50: 362–365

    Article  PubMed  CAS  Google Scholar 

  30. Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41: 1103–1110

    Article  PubMed  CAS  Google Scholar 

  31. Daunt AO, Cox NL, Robertson JC, Cawley MI (1987) Indices of disease activity in psoriatic arthritis. J R Soc Med 80: 556–558

    PubMed  CAS  Google Scholar 

  32. Laurent MR, Panayi GS, Shepherd P (1981) Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis 40: 66–69

    Article  PubMed  CAS  Google Scholar 

  33. Salvarani C, Cantini F, Olivieri I, Macchioni P, Padula A, Niccoli L, et al. (2003) Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum 49: 541–545

    Article  PubMed  CAS  Google Scholar 

  34. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62: 870–874

    Article  PubMed  CAS  Google Scholar 

  35. Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29: 2074–2076

    PubMed  Google Scholar 

  36. Terzoglou K, Papaventsis DC, Theodoropoulou G, Kremasmenou E, Cherouvim E, Boki K (2003) Anticitrullinated peptides detection and diagnosis of rheumatoid arthritis (abst.). Ann Rheum Dis 62(Suppl 1): THU0130

    Google Scholar 

  37. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van’t Hof M, et al. (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43: 1831–1835

    Article  PubMed  CAS  Google Scholar 

  38. Nell VPK, Machold KP, Eberl G, Hiesberger H, Hoefler E, Smolen JS, et al. (2003) The diagnostic and prognostic significance of autoantibodies in patients with very early arthritis (abst.). Ann Rheum Dis 62(Suppl 1): abstract #OP0015

    Google Scholar 

  39. Mettler S, Roch A, Langer H (2003) Antibodies against cyclic citrullinated peptide (CCP; filaggrin) in daily rheumatology practice: highly specific in diagnosis of rheumatoid arthritis (abst.). EULAR 2003 Abstracts: AB0074

    Google Scholar 

  40. Pincus T, Callahan LF, Fuchs HA, Larsen A, Kaye J (1995) Quantitative analysis of hand radiographs in rheumatoid arthritis: time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol 22: 1983–1989

    PubMed  CAS  Google Scholar 

  41. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140: 659–662

    PubMed  CAS  Google Scholar 

  42. Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 18: 481–491

    CAS  Google Scholar 

  43. Rau R, Herborn G (1995) A modified version of Larsen’s scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22: 1976–1982

    PubMed  CAS  Google Scholar 

  44. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D (1998) Radiological assessment in psoriatic arthritis. Br J Rheumatol 37: 760–765

    Article  PubMed  CAS  Google Scholar 

  45. Sharp JT (2000) An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis. J Rheumatol 27: 254–260

    PubMed  CAS  Google Scholar 

  46. van der Heijde D (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 27: 261–263

    PubMed  Google Scholar 

  47. Arreghini M, Panni B, Arnoldi C, Battafarano N, Gibelli E, Tosi S, et al. (2003) Radiographic evaluation of long-standing peripheral psoriatic arthritis: usefulness of a modified version of the Sharp/Van der Heijde method (abst.). Ann Rheum Dis 62(Suppl 1): abstract #FRI0155

    Google Scholar 

  48. Ory P, Sharp JT, Salonen D, Rubenstein J, Mease PJ, Kivitz AJ, et al. (2002) Etanercept inhibits radiographic progression in patients with psoriatic arthritis (abst.). Arthritis Rheum 46(Suppl 9): S196

    Google Scholar 

  49. Ory P, Sharp JT, Salonen D, Rubenstein JD, Mease PJ, Ruderman EM, et al. (2003) Etanercept inhibits radiographic progression in patients with psoriatic arthritis. Ann Rheum Dis 62(Suppl 1): abstract #OP0089

    Google Scholar 

  50. Wassenberg S, Fischer-Kahle V, Herborn G, Rau R (2001) A method to score radiographic change in psoriatic arthritis. Z Rheumatol 60: 156–166

    Article  PubMed  CAS  Google Scholar 

  51. van der Heijde DM (2004) Assessment of radiographs in longitudinal observational studies. J Rheumatol Suppl 69: 46–47

    Google Scholar 

  52. van Tubergen A, Heuft-Dorenbosch L, Schulpen G, Landewe R, Wijers R, van der Heijde D, et al. (2003) Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 62: 519–525

    Article  PubMed  Google Scholar 

  53. MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41: 2263–2270

    Article  PubMed  CAS  Google Scholar 

  54. Calin A, Mackay K, Santos H, Brophy S (1999) A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol 26: 988–992

    PubMed  CAS  Google Scholar 

  55. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359: 1187–1193

    Article  PubMed  CAS  Google Scholar 

  56. Creemers M, Franssen M, Hof Mv M, Gribnau F, Van De Putte L, Van Riel P (2004) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis (in press)

    Google Scholar 

  57. Kalden-Nemeth D, Grebmeier J, Antoni C, Manger B, Wolf F, Kalden JR (1997) NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy. Rheumatol Int 16: 249–255

    Article  PubMed  CAS  Google Scholar 

  58. Antoni C, Dechant C, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M, et al. (2002) Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 47: 506–512

    Article  PubMed  CAS  Google Scholar 

  59. Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, et al. (2002) Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 61: 895–904

    Article  PubMed  CAS  Google Scholar 

  60. Alcade M, Cruz M, Bordoy C, Gonzalez L, Acebes C, Sanchez-Pernaute O, et al. (2002) Assessment of entheseal injury in ankylosing spondylitis by ultrasound (abst.). Arthritis Rheum 46(Suppl 9): S427

    Google Scholar 

  61. Kamel M, Mansour R, Eid H, Ferandez I (2002) Ultrasound detection of patellar enthesitis: a comparison with MRI (abst.). Arthritis Rheum 46(Suppl 9): S104

    Google Scholar 

  62. Klauser A, Springer P, Frauscher F, Schirmer M (2002) Comparison between magnetic resonance imaging, unenhanced and contrast enhanced ultrasound in the diagnosis of active sacroiliitis (abst.). Arthritis Rheum 46(Suppl 9): S426

    Google Scholar 

  63. Oostveen J, Prevo R, den Boer J, van de Laar M (1999) Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J Rheumatol 26: 1953–1958

    PubMed  CAS  Google Scholar 

  64. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, et al. (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48: 1126–1136

    Article  PubMed  CAS  Google Scholar 

  65. Braun J, Baraliakos X, Golden W, Listing J, Brandt J, Bollow M, et al. (2002) Ankylosing spondylitis (AS) — development and evaluation of a spinal scoring system (ASspiMRI) using magnetic resonance imaging (MRI) in patients with active disease (abst.). Arthritis Rheum 46(Suppl 9): S426

    Google Scholar 

  66. Braun J, Baraliakos X, Golden W, Listing J, Brandt J, Bollow M, et al. (2002) Improvement of spinal inflammation in ankylosing spondylitis (AS) by infliximab therapy as assessed by a magnetic resonance imaging (MRI) using a novel evaluated spinal scoring system — results of a double-blind placebocontrolled trial (abst.). Arthritis Rheum 46(Suppl 9): S426–S427

    Google Scholar 

  67. Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W (2004) Assessment of patients with psoriatic arthritis: a review of currently available measures. Arthritis Rheum 50: 24–35

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology & Medicine, Hospital for Joint Diseases, New York, NY, USA

    Soumya M. Reddy MD

  2. Johns Hopkins University, Baltimore, MD, USA

    Clifton O. Bingham III MD

Authors
  1. Soumya M. Reddy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clifton O. Bingham III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Loyola University, Stritch School of Medicine, 2160 S. First Ave., Building 112, Room 342, Maywood, IL, 60153, USA

    Kenneth B. Gordon MD

  2. Division of Rheumatology, Northwestern University, Feinberg School of Medicine, 675 N. St. Clair St., Chicago, IL, 60611, USA

    Eric M. Ruderman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reddy, S.M., Bingham, C.O. (2005). Psoriatic Arthritis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_11

Download citation

  • DOI: https://doi.org/10.1007/3-540-27190-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21280-5

  • Online ISBN: 978-3-540-27190-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation